Literature DB >> 22964525

Matrix metalloproteinase (MMP)-2 and MMP-9 expression in tumor infiltrating CD3 lymphocytes from women with endometrial cancer.

Marcin Jedryka1, Agnieszka Chrobak, Anna Chelmonska-Soyta, Daria Gawron, Alicja Halbersztadt, Andrzej Wojnar, Jan Kornafel.   

Abstract

OBJECTIVE: In this study, we hypothesized that not only endothelial malignant cells but also lymphocytes infiltrating tumor epithelium, in patients with endometrial cancer, could be an important source of the gelatinases (matrix metalloproteinase [MMP]-2 and MMP-9) extensive production, which in turn, may facilitate tumor cells infiltration and progression due to the extracellular matrix degradation.
MATERIALS AND METHODS: First, we isolated lymphocytes from the endometrial carcinoma samples taken from 41 patients who were operated on and from healthy endometrial tissue taken of the same patients after histological verification. Then, we detected the level of CD3-positive cells in endometrial tissues by flow cytometry. Simultaneously, we studied the messenger RNA expression of MMP-2 and MMP-9 in the isolated cells from malignant and unchanged endometrial tissues. Using immunohistochemistry, we compared the protein expression of MMP-2, MMP-9, and CD3 in the studied samples.
RESULTS: We showed the enhanced abundance of CD3 lymphocytes both by flow cytometry and immunohistochemistry in the samples from malignant tissues. The expression of MMP-9 in the endometrial carcinoma was increased significantly at the protein level but not at the messenger RNA level. We could not observe any differences concerning MMP-2 expression in both methods of detection.
CONCLUSIONS: CD-3 lymphocytes significantly infiltrate endometrial cancer tissue, but they do not seem to be the source of enhanced metalloproteinases 2 and 9 expression in the tumor environment. Still, owing to the immunohistochemistry staining, we could show the significant increase of MMP-9 protein in the very close vicinity of tumor-infiltrating CD3 lymphocytes. Could it be the result of CD3 lymphocyte action, or is it just the imperfection of the detecting method we used? This remains unclear. Further studies explaining the role of tumor infiltrating lymphocytes in mediating the endometrial cancer milieu are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964525     DOI: 10.1097/IGC.0b013e318269e27b

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

1.  Kisspeptin regulation of human decidual stromal cells motility via FAK-Src intracellular tyrosine kinases.

Authors:  H-M Wu; H-Y Huang; Y-K Soong; P C K Leung; H-S Wang
Journal:  Hum Reprod       Date:  2019-07-08       Impact factor: 6.918

Review 2.  Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.

Authors:  Nabil M Abdel-Hamid; Shimaa A Abass
Journal:  Mol Biol Rep       Date:  2021-08-11       Impact factor: 2.316

Review 3.  Impact of the Tumor Microenvironment for Esophageal Tumor Development-An Opportunity for Prevention?

Authors:  Martin Borgmann; Michael Quante
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

4.  Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium.

Authors:  Meng Zhou; Si Qin; Yang Chu; Fengming Wang; Lujun Chen; Yahua Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

5.  β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition.

Authors:  Seo Jin Oh; Jung-Ho Shin; Tae Hoon Kim; Hee Sun Lee; Jung-Yoon Yoo; Ji Yeon Ahn; Russell R Broaddus; Makoto M Taketo; John P Lydon; Richard E Leach; Bruce A Lessey; Asgerally T Fazleabas; Jeong Mook Lim; Jae-Wook Jeong
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

6.  α-bisabolol enhances radiotherapy-induced apoptosis in endometrial cancer cells by reducing the effect of XIAP on inhibiting caspase-3.

Authors:  Dongmei Fang; Hongxin Wang; Min Li; Wenwen Wei
Journal:  Biosci Rep       Date:  2019-06-10       Impact factor: 3.976

7.  The NOTCH1-HEY1 pathway regulates self-renewal and epithelial-mesenchymal transition of salivary adenoid cystic carcinoma cells.

Authors:  Jing Xie; Li-Song Lin; Xiao-Yu Huang; Rui-Huan Gan; Lin-Can Ding; Bo-Hua Su; Yong Zhao; You-Guang Lu; Da-Li Zheng
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

8.  Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.

Authors:  Pu Cheng; Jiong Ma; Xia Zheng; Chunxia Zhou; Xuejun Chen
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

9.  Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2.

Authors:  Hsien-Ming Wu; Hsin-Shih Wang; Hong-Yuan Huang; Chyong-Huey Lai; Chyi-Long Lee; Yung-Kuei Soong; Peter Ck Leung
Journal:  BMC Cancer       Date:  2013-06-20       Impact factor: 4.430

10.  MMP2 as an independent prognostic stratifier in oral cavity cancers.

Authors:  Caroline Hoffmann; Sophie Vacher; Philémon Sirven; Charlotte Lecerf; Lucile Massenet; Aurélie Moreira; Aurore Surun; Anne Schnitzler; Jerzy Klijanienko; Odette Mariani; Emmanuelle Jeannot; Nathalie Badois; Maria Lesnik; Olivier Choussy; Christophe Le Tourneau; Maude Guillot-Delost; Maud Kamal; Ivan Bieche; Vassili Soumelis
Journal:  Oncoimmunology       Date:  2020-05-13       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.